New data show midkine expression is heightened in small cell lung cancer, suggesting the growth factor may be an important ...

David Baker’s Nobel Prize-winning lab has generated AI-designed proteins to enhance the immune system's ability to detect and ...

A new study has found that patients with metastatic non–small cell lung cancer and pre-existing rheumatoid arthritis have similar overall survival to those without RA when treated with immune ...

Some lung cancers do not respond well to immunotherapy, a treatment that helps the body’s immune system attack cancer. But a new study shows that radiation therapy might help solve this problem. The ...

Weill Cancer Hub West will harness genomics, big data, AI, and machine learning to counter California’s 20 new cancer cases ...

Discover how CRISPR gene editing is creating personalized cancer therapies, enhancing immunotherapy, and offering new hope ...

Fotivda preserved quality-of-life scores in kidney cancer, with better outcomes in second-line use and no added benefit from combining with Opdivo.

During a live event, Bruna Pellini, MD, discussed the efficacy of cemiplimab in PD-L1-high non–small cell lung cancer.

Cancer cells and tumors do not exist in a vacuum. Far from the isolation and self-sufficiency of the fictional Wakanda, tumors develop in and alter the nearby milieu of immune cells, connective tissue ...

The experimental mRNA vaccine developed at the University of Florida has shown the ability to supercharge the immune system ...

A team used generative AI to enhance T cells’ ability to fight melanoma. The immunotherapy approach needs more testing before use in cancer patients.

A breakthrough for the customized treatment of cancer and other diseases is so promising that University of Washington ...